USPTO serial 77784514
RESPIRATORY HEALTH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LORENZO, KATHLEEN H
- Law office
- TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with RESPIRATORY HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer L. Whitelaw
JENNIFER L. WHITELAW WHITELAW LEGAL GROUP3838 TAMIAMI TRL N STE 310NAPLES, FL 34103-3586UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietary herbal extracts and blends used as an ingredient in functional foods or beverages; medicinal herbal extracts and blends used as an ingredient in medicinal foods or beverages; medicinal botanical extracts and blends used as an ingredient in functional foods or beverages; dietary and/or medicinal botanical extracts and blends used as an ingredient in medicinal foods or beverages; nutritional supplements, namely, botanical extracts for nutritional use; herbal products, namely, medicated skin and lip balms; medicated herbal products, namely, ointments, oils, drinks, infusions, syrups, herbal extracts, poisons, tinctures for medical use in the treatment of strokes, infarcts and other cardiovascular and cerebrum diseases; medicated herbal products, namely, ointments, oils, namely, fish extract oils, nutritional oils not for cosmetic purposes, vitamin oils for human consumption; drinks, namely, meal replacement drinks, dietary supplement drinks, medicinal drinks, and fish oil for use as a dietary supplement or in a nutraceutical infusion, syrups, namely, cough syrups; herbal products for medicinal purposes, namely, herbal extracts for use as nutritional and dietary supplements; herbal products for medicinal purposes, namely, herbal extracts and syrups; medicinal herb extracts for medicinal purposes; plant extracts for medical, nutraceutical, pharmaceutical and nutritional purposes; yeast extracts for medical, nutraceutical or pharmaceutical purposes; medicinal extracts used in preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection for medical purposes; medicinal extracts used in pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection for medical purposes; medicinal herbal extracts used as component ingredients of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection for medical purposes; botanical extracts used as component ingredients of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection used to treat skin ailments, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; yeast extracts for medical, nutraceutical or pharmaceutical purposes; herbal food supplements products, namely, herbal powders for nutritional purposes; herbal products, namely, herbal meal replacement powders for dietary and nutritional purposes; herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; herbal products, namely, herbal powders sold as an integral ingredient of nutritional supplement drink mix for nutritional purposes; pharmaceuticals and nutraceuticals, namely, vitamins and food supplements; pharmaceutical preparations, namely, appetite suppressants and lipid lowering agents; food for diabetics, infants and enteral feeding; nutritional supplements, namely, botanical extracts for nutritional use; botanical extracts used as ingredients in pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; botanical extracts for use in nutraceuticals and pharmaceuticals; botanical extracts for medical, veterinary, nutraceutical and pharmaceutical purposes; designer extracts, namely, herbal extracts for medical, veterinary and pharmaceutical purposes; botanical extracts sold as an integral ingredient of nutritional supplements, nutraceuticals and pharmaceuticals; herbal preparations and extracts for use as ingredients in the food, nutrition, nutraceutical and/or pharmaceutical industry; nutritional dietary supplements; oral preparations containing herbs or herbal extracts used to maintain health and for a wide variety of physical conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; vitamin and mineral preparations intended for use as dietary supplements; vitamins; food supplements; nutraceuticals, namely, vitamins and food supplements; food for medically restricted diets; supplements, namely, lipid concentrates for use as a dietary food supplement or for pharmaceutical or medicinal purposes; food supplements, namely, anti-oxidants; botanicals and botanical blends, herbals and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, all sold as components of nutritional supplements and vitamins; nutritional oils not for cosmetic purposes; food supplements, namely, lipid concentrates for use as a dietary food supplement or for pharmaceutical or medicinal purposes; anti-cough drops; cough drops; cough expectorants; throat lozenges; cough lozenges; cough syrups; cough treatment preparations; cold sore treatment preparations; pharmaceutical antitussive-cold preparations; preparations for treating colds; analgesic preparations; analgesics; antipyretic analgesics; ibuprofen for use as an oral analgesic; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; oral analgesics; topical analgesics; pharmaceutical preparations for the treatment and prevention of herpes; vaccines for the treatment and prevention herpes; biological preparations for the treatment and prevention of herpes; pharmaceutical preparations for the treatment of herpes simplex infection; pharmaceutical capsules for the treatment of herpes simplex infection; homeopathic preparations for the treatment of herpes and cold sores; pharmaceutical preparations for the treatment of herpes viruses; medicated topical clear fluoride gel for the treatment of herpes virus during the physical manifestation of the virus; pharmaceutical preparations for the treatment of herpes simplex virus type I or type ii or herpes zoster virus, not in intravenous form; plant based antivirals; over-the-counter topical antivirals; pharmaceutical preparation with antiviral and/or antimicrobial properties for use in the treatment of herpetic keratitis, conjunctivitis, HIV retinopathy, viral influenza "flu", herpes simplex virus 1, herpes simplex virus 2, varicella zoster virus "herpes zoster" or "shingles", cytomegalovirus, viral parainfluenza, adenovirus, viral encephalitis, viral meningitis, arbovirus, arenavirus, picornavirus, coronavirus, syntialvirus, viral infections, common colds caused by viruses, cold sores, human immunodeficiency virus "hiv", roseola infantum, human herpes IV; pharmaceutical preparations for the treatment of viral diseases and disorders, namely, herpes; pharmaceutical preparations for treating immune diseases induced by virus, namely, herpes, herpes zoster and AIDS; algal products for medicinal purposes, namely, algal extracts or algal extract blends for use as nutritional and dietary supplements; algal products, namely, algal powders sold as an integral ingredient of nutritional supplement drink mix for nutritional purposes; algal nutritional supplement products, namely, algal powders for use as a nutritional supplement; algal extracts or algal extract blends for medical or pharmaceutical purposes; functional foods, namely, dietetic foods adapted for medical purposes, food for diabetics, infants and enteral feeding, food for medically restricted diets; functional beverages, namely, nutritionally fortified beverages; nutritionally fortified beverages for immune enhancement, and nutritionally fortified beverages with rice bran and wheat bran; medicinal beverages; soy protein for use as a nutritional supplement; nutritional additives for medical or nonmedical purposes for use in manufacturing foods and dietary supplements for human consumption; medicinal foods, namely, processed food for medical purposes; animal health products, namely, animal feed supplements, medicated animal feed, micro-nutrient animal feed, dietary supplements for animals, non-medicated additives for animal feed for use as nutritional supplements, nutritional drinks for animals, pharmaceutical preparations for animal skincare; plant extracts for medical, veterinary and pharmaceutical purposes; botanical extracts for medical, veterinary and pharmaceutical purposes; herbal extracts for medical, veterinary and pharmaceutical purposes; designer extracts, namely, plant, herbal and botanical extracts for medical, veterinary and pharmaceutical purposes; biodefense products, namely, medicinal preparations for the treatment of infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; mushroom, fungus, or spore extracts or blends for use as ingredients in functional foods, nutraceutical or pharmaceutical preparations; active principles extracted from medicinal plants for use in the manufacture of nutraceuticals and pharmaceuticals; active principles extracted from medicinal plants for use in the manufacture of pharmaceutical or nutraceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 21, 2010 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 20, 2010 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 22, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 23, 2009 | NWAP | NEW APPLICATION ENTERED | — |